夜间收缩期高血压与CKD患者不良预后相关
该研究基于中国慢性肾脏病队列2024例CKD 1-4期患者,将夜间高血压分为单纯舒张期、单纯收缩期及收缩-舒张期三型,用Cox回归分析其与肾衰竭和心血管结局的关联。结果显示单纯夜间收缩期高血压与心血管事件风险升高相关,收缩-舒张期高血压与肾衰竭和心血管事件风险均升高相关,而单纯夜间舒张期高血压无显著关联。
要点
- 夜间收缩期高血压(无论是否合并舒张期)与CKD患者不良预后相关。
- 单纯夜间收缩期高血压者心血管事件风险显著升高(HR 3.17)。
- 夜间收缩-舒张期高血压者肾衰竭和心血管事件风险均升高。
核心结论
- 夜间收缩期高血压,无论单独或合并舒张期高血压,均与CKD患者不良结局风险升高相关。
研究设计与样本
- 研究分析中国慢性肾脏病队列数据,纳入2024例CKD 1-4期患者,平均年龄49±14岁,57%为男性,eGFR为51±29 ml/min per 1.73 m2,蛋白尿为0.9(0.4-2.1)g/d。
- 采用Cox回归评估夜间高血压各型与肾衰竭和心血管结局的关联。
主要发现
- 73%(1484例)患者有夜间高血压,其中单纯夜间舒张期高血压占26%,单纯夜间收缩期高血压占8%,夜间收缩-舒张期高血压占66%。
- 调整后,单纯夜间收缩期高血压与心血管事件风险升高相关(HR 3.17;95%CI 1.61-6.23)。
- 夜间收缩-舒张期高血压与肾衰竭风险升高(HR 1.71;95%CI 1.17-2.49)及心血管结局风险升高(HR 2.19;95%CI 1.24-3.86)相关。
- 单纯夜间舒张期高血压与肾衰竭或心血管事件无显著关联。
关键数值与推荐
- 单纯夜间舒张期高血压定义为舒张压≥70 mmHg且收缩压<120 mmHg。
- 单纯夜间收缩期高血压定义为收缩压≥120 mmHg且舒张压<70 mmHg。
- 夜间收缩-舒张期高血压定义为收缩压≥120 mmHg且舒张压≥70 mmHg。
临床怎么用
- 在CKD患者中应关注夜间血压模式,特别是夜间收缩压升高,以识别心血管和肾脏事件高风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Nocturnal hypertension is associated with adverse outcomes in patients with CKD. However, the individual association of entities of nocturnal hypertension according to achievement of systolic and/or diastolic BP goals with kidney failure and cardiovascular outcomes of CKD is not clear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study analyzed data from participants in the Chinese Cohort Study of Chronic Kidney Disease. Nocturnal hypertension was categorized into three entities: isolated nocturnal diastolic hypertension with diastolic BP ≥70 mm Hg and systolic BP <120 mm Hg, isolated nocturnal systolic hypertension with systolic BP ≥120 mm Hg and diastolic BP <70 mm Hg, and nocturnal systolic-diastolic hypertension with both systolic BP ≥120 mm Hg and diastolic BP ≥70 mm Hg. Associations of nocturnal hypertension entities with kidney failure and cardiovascular outcomes were evaluated by Cox regression. RESULTS: In total, 2024 patients with CKD stages 1-4 were included in our analysis (mean age, 49±14 years; 57% men; eGFR=51±29 ml/min per 1.73 m2; proteinuria: 0.9 [0.4-2.1] g/d). Among them, 1484 (73%) patients had nocturnal hypertension, with the proportions of 26%, 8%, and 66% for isolated nocturnal diastolic hypertension, isolated nocturnal systolic hypertension, and nocturnal systolic-diastolic hypertension, respectively. Three hundred twenty kidney events and 148 cardiovascular events were recorded during median follow-up intervals of 4.8 and 5.0 years for kidney and cardiovascular events, respectively. After adjustment, isolated nocturnal systolic hypertension was associated with a higher risk for cardiovascular events (hazard ratio, 3.17; 95% confidence interval, 1.61 to 6.23). Nocturnal systolic-diastolic hypertension showed a higher risk for both kidney failure (hazard ratio, 1.71; 95% confidence interval, 1.17 to 2.49) and cardiovascular outcomes (hazard ratio, 2.19; 95% confidence interval, 1.24 to 3.86). No association was observed between isolated nocturnal diastolic hypertension with either kidney failure or cardiovascular events. CONCLUSIONS: Nocturnal systolic hypertension, either alone or in combination with diastolic hypertension, is associated with higher risks for adverse outcomes in patients with CKD.
引用
- Wang Q, Wang Y, Wang J, et al. Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD. Clin J Am Soc Nephrol. 2021. PMID: 33568382. doi:10.2215/CJN.14420920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。